Details of Viral Vaccine
This Viral vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 10188 |
| Vaccine Name | Covax-19 |
| Disease Name | COVID-19 |
| Disease Classification | Respiratory |
| Virus Name | SARS-CoV-2 virus |
| Nucleic Acid Content | positive-sense, single-stranded RNA |
| Vaccine Type | Protein subunit |
| Vaccine Status | Phase 1 |
| Manufacturer | GeneCure Biotechnologies |
| Year of Manufacturing | 2020 |
| Manufacturing Country | USA |
| Age | 18 - 60 years |
| Dosage | 2 doses 2 weeks apart |
| Administration Route | Intramuscular |
| Adjuvant | NA |
| Target Strain | NA |
| Description | NA |
| Approving Organisation | US FDA |
| Collaborating Organisation | NA |
| Other Countries | NA |
| Trade Name | NA |
| PMID | NA |
| Clinical Trial ID | NCT04428073 |
| Reference Link | https://clinicaltrials.gov/show/NCT04428073 |
| Additional Links | https://delta.larvol.com/Products/bac627c1e3c7453f9c3e06990d38d930/COVAX19GC004/0/11eb4d064c904d80ad7af09be3dfc6e8/COVAX19-Monovalent-Recombinant-COVID19-Vaccine/ |